Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $93

Benzinga Newsdesk www.benzinga.com Positive 72.8%

Neg 0% Neu 0% Pos 72.8%

Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $89 to $93.